CME Offered on In-Hospital Off-Label Uses of Recombinant Factor VIIa

CME Offered on In-Hospital Off-Label Uses of Recombinant Factor VIIa



A CME module offered by AHRQ’s Effective Health Care Program, Comparative Effectiveness of In-Hospital Off-Label Use of Recombinant Factor VIIa vs. Usual Care, offers an AMA PRA Category 1 Credit™ based on a comparative study of the utilization and effectiveness of the use of rFVIIa. The study found that current evidence does not show that off-label use of rFVIIa reduces mortality or improves other direct outcomes. Thromboembolic events are increased by use of rFVIIa to threat spontaneous intracranial hemorrhage and in adult cardiac surgery. The EHC program also offers a guide for clinicians, Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor VIIa.
Search for Guides, Reviews, and Reports | AHRQ Effective Health Care Program